A Rare Presentation of Progressive Disseminated Histoplasmosis in an Immunocompetent Patient from a Non-Endemic Region

Total Page:16

File Type:pdf, Size:1020Kb

A Rare Presentation of Progressive Disseminated Histoplasmosis in an Immunocompetent Patient from a Non-Endemic Region Medical Mycology Case Reports 2 (2013) 103–107 Contents lists available at ScienceDirect Medical Mycology Case Reports journal homepage: www.elsevier.com/locate/mmcr A rare presentation of progressive disseminated histoplasmosis in an immunocompetent patient from a non-endemic region M.V.S. Subbalaxmi a,n, P. Umabala b, Roshni Paul c, Naval Chandra a, Y.S. Raju a, Shivaprakash M. Rudramurthy d a Department of General Medicine, Nizam's Institute of Medical Sciences, Hyderabad 500082, Andhra Pradesh, India b Department of Microbiology, Nizam's Institute of Medical Sciences, Hyderabad 500082, Andhra Pradesh, India c Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad 500082, Andhra Pradesh, India d Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India article info abstract Article history: Histoplasmosis is an important systemic fungal infection in endemic areas. In India, the disease has been Received 2 January 2013 reported from several parts of the country, most cases being from eastern India considered to be endemic Received in revised form for the disease. There have been very few cases reported from the state of Andhra Pradesh, in the 12 April 2013 southern part of India. We report a case of progressive disseminated histoplasmosis presenting with Accepted 15 April 2013 bleeding manifestations in an immune competent patient from the state of Andhra Pradesh. & 2013 International Society for Human and Animal Mycology. Published by Elsevier B.V All rights Keywords: reserved. Histoplasmosis PDH Immunocompetent host Thrombocytopenia India 1. Introduction in a patient with no underlying risk factor for progressive dissemi- nated histoplasmosis. Histoplasmosis caused by the dimorphic fungus Histoplasma capsulatum presents most commonly as pulmonary and progressive disseminated (PDH) forms [1].Approximately10%ofindividuals 2. Case infected with histoplasmosis may develop progressive disseminated histoplasmosis which usually presents with fever, malaise, hepa- A male farmer aged 56 years from Adilabad district, in Andhra tosplenomegaly and lymphadenopathy. Other manifestations of Pradesh, was admitted on day 0 to a tertiary care hospital in PDH include pancytopenia, renal failure, disseminated intra vascular Andhra Pradesh, south India with complaints of hematuria and coagulation (DIC), skin lesions, gastrointestinal manifestations like epigastric pain for last 15 days. Epigastric pain was more after diarrhea, vomiting, neurologic manifestations like encephalopathy, taking food but there was no history of radiation. He complained focal parenchymal lesions and sometimes adrenal insufficiency [1]. of nausea though there was no history of vomiting and fever. Progressive disseminated histoplasmosis is usually seen in immu- Patient was admitted to another hospital 5 days prior to the nocompromised patients such as persons with HIV infection [1].In present admission for evaluation of his epigastric pain. Upper India histoplasmosis has been reported from different pockets in gastrointestinal endoscopy was done there, which revealed gas- the eastern, north eastern, northern, western and southern parts of tritis. In view of very low platelet counts he was referred to our the country [2–10].We report a case of progressive disseminated hospital. There was no history of smoking or substance abuse or histoplasmosis in an immunocompetent patient, presenting with travel outside the state of Andhra Pradesh to any regions known to bleeding manifestations from the state of Andhra Pradesh in the be endemic for histoplasmosis. southern part of India. This case merits discussion due to the rarity At admission on day 0, general physical examination revealed of the presentation mimicking immune thrombocytopenic purpura, petechiae on his right shoulder and tenderness in the epigastric area. Rest of the general examination and systemic examination were normal. Laboratory work up done on day +1 revealed hemoglobin n fl Corresponding author. Tel.: +91 409490457909. 12.1 g/dl; mean corpuscular volume 86 ; total leukocyte count E-mail address: [email protected] (M.V.S. Subbalaxmi). 4000/cmm with normal differential count; platelet count 10,000/cmm. 2211-7539/$ - see front matter & 2013 International Society for Human and Animal Mycology. Published by Elsevier B.V All rights reserved. http://dx.doi.org/10.1016/j.mmcr.2013.04.003 104 M.V.S. Subbalaxmi et al. / Medical Mycology Case Reports 2 (2013) 103–107 ESR was within normal limits. Peripheral blood smear showed (Fig. 2A). Large number of histiocytes, some foamy, filled with tiny thrombocytopenia (Fig. 1A) with giant platelets (Fig. 1B). Complete intracytoplasmic yeasts were seen. There were a few yeasts lying urine examination showed plenty of red blood cells. Random extracellularly. These were oval, 2–3 m in size with a slightly blood sugar, glycosylated hemoglobin, coagulation profile, liver eccentric nucleus and a clear zone around the nucleus (Fig. 2B). and renal function tests serum lipase were all within normal As these organisms had to be differentiated from others with limits; serum amylase was 150 U/ml and LDH 2260 U/L. ELISAs for similar morphology, trephine sections were subjected to special anti-nuclear antibodies, HIV antibody and HIV antigen were all staining with periodic acid schiff (PAS) (Fig. 3A) and silver negative. methanamine (SM) (Fig. 3B),which showed yeast cells morpholo- In view of the age and persisting thrombocytopenia, a bone gically suggestive of H. capsulatum. marrow aspiration and biopsy were done on day +3 to rule out As the bone marrow aspirate was not sent for culture at the lymphoma. Bone marrow aspirate was particulate with normal first instance, repeated bone marrow aspiration was done on day cellularity, M:E ratio was 2:1, with normal erythropoeisis and +7 for confirmation of histoplasmosis. The aspirate was inoculated myelopoeisis. Megakaryocytes were slightly increased in number on to brain heart infusion agar, Sabouraud's dextrose agar with Fig. 1. Leishman stain: peripheral blood smear showing (A) thrombocytopenia (  400) with (B) giant platelets (  1000). Fig. 2. (A) Giemsa  400: BMA particulate with normal cellularity, M:E ratio 2:1, normal erythropoiesis, myelopoiesis, megakarycytes slightly increased in number with normal morphology. (B) Giemsa  400 (inset Giemsa  1000): histiocytes showing intracytoplasmic yeasts. M.V.S. Subbalaxmi et al. / Medical Mycology Case Reports 2 (2013) 103–107 105 Fig. 3. Trephine section showing yeast cells stained with PAS (A) and SM (B) (  400). 2.1. Imaging Chest radiograph and ultrasound scanning of abdomen which were done on day +3 of hospital stay were normal. 2.2. Treatment The patient’s platelet counts at admission were 10,000/cmm and were continuing to fall further for which he received platelet transfusions on alternate days. On day +8, patient was started on treatment with injection amphotericin B deoxycholate at a daily dose of 1 mg/kg b wt. Pain abdomen gradually subsided and the patient’s appetite improved. Platelet count increased to 30,000/ cmm on day +13 i.e. after 5 days of starting of amphotericin. Patient was given amphotericin B deoxycholate for 14 days Fig. 4. Lactophenol cotton blue mount (  400): large, rounded, single-celled, tuberculate macroconidia and small, pyriform shaped microconidia of Histoplasma followed by itraconazole 200 mg twice a day with a plan to capsulatum. (For interpretation of the references to color in this figure caption, the continue for 1 year. Platelet count was 50,000/cmm at discharge reader is referred to the web version of this article.) on day +22. ' chloramphenicol, and Sabouraud s dextrose agar with cyclohex- 2.3. Follow up and outcome imide and chloramphenicol. As H. capsulatum is a CDC/NIH risk group 3 agent, handling of clinical material and isolates were done Patient reported to the general medicine outpatient depart- in the Class II Bio Safety Cabinet with BSL2 practices, containment ment for follow up on day +52. Patient showed marked clinical ' 1 equipment and facilities. On Sabouraud s dextrose agar at 25 C, improvement and platelet counts on that day were 150,000/cmm. + colonies appeared after 1 week of incubation i.e. on day 14. The Platelet count was 160,000/cmm at the next folloup on day+112. colonies were highly folded, adherent, initially white, turning buff- The patient's renal function and liver function were monitored brown. Microscopic morphology showed the presence of charac- throughout the course of treatment with antifungals till his last teristic large, rounded, single-celled, tuberculate macroconidia and visit (day 112) to the outpatient department for follow up and small, pyriform shaped microconidia (Fig. 4), based on which the were found to be within normal limits. fungus provisionally was identified as H. capsulatum. The isolate was sent to the National Culture Collection of Pathogenic Fungi (NCCPF), Postgraduate Institute of Medical Education and 3. Discussion Research, Chandigarh, for confirmation. At NCCPF, the identity of the isolate was confirmed by morphology, conversion to yeast H. capsulatum causing histoplasmosis is presently classified into phase and sequencing of rDNA. For extraction of DNA, the isolate six distinct clades based on combined data analysis of partial was inoculated in Sabouraud dextrose broth and incubated in a sequences of four protein encoding genes of 46H. capsulatum shaker incubator (130 rpm) at 35 1C for 5 days. The cells were
Recommended publications
  • Estimated Burden of Serious Fungal Infections in Ghana
    Journal of Fungi Article Estimated Burden of Serious Fungal Infections in Ghana Bright K. Ocansey 1, George A. Pesewu 2,*, Francis S. Codjoe 2, Samuel Osei-Djarbeng 3, Patrick K. Feglo 4 and David W. Denning 5 1 Laboratory Unit, New Hope Specialist Hospital, Aflao 00233, Ghana; [email protected] 2 Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, P.O. Box KB-143, Korle-Bu, Accra 00233, Ghana; [email protected] 3 Department of Pharmaceutical Sciences, Faculty of Health Sciences, Kumasi Technical University, P.O. Box 854, Kumasi 00233, Ghana; [email protected] 4 Department of Clinical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi 00233, Ghana; [email protected] 5 National Aspergillosis Centre, Wythenshawe Hospital and the University of Manchester, Manchester M23 9LT, UK; [email protected] * Correspondence: [email protected] or [email protected] or [email protected]; Tel.: +233-277-301-300; Fax: +233-240-190-737 Received: 5 March 2019; Accepted: 14 April 2019; Published: 11 May 2019 Abstract: Fungal infections are increasingly becoming common and yet often neglected in developing countries. Information on the burden of these infections is important for improved patient outcomes. The burden of serious fungal infections in Ghana is unknown. We aimed to estimate this burden. Using local, regional, or global data and estimates of population and at-risk groups, deterministic modelling was employed to estimate national incidence or prevalence. Our study revealed that about 4% of Ghanaians suffer from serious fungal infections yearly, with over 35,000 affected by life-threatening invasive fungal infections.
    [Show full text]
  • Therapeutic Class Overview Onychomycosis Agents
    Therapeutic Class Overview Onychomycosis Agents Therapeutic Class • Overview/Summary: This review will focus on the antifungal agents Food and Drug Administration (FDA)-approved for the treatment of onychomycosis.1-9 Onychomycosis is a progressive infection of the nail bed which may extend into the matrix or plate, leading to destruction, deformity, thickening and discoloration. Of note, these agents are only indicated when specific types of fungus have caused the infection, and are listed in Table 1. Additionally, ciclopirox is only FDA-approved for mild to moderate onychomycosis without lunula involvement.1 The mechanisms by which these agents exhibit their antifungal effects are varied. For ciclopirox (Penlac®) the exact mechanism is unknown. It is believed to block fungal transmembrane transport, causing intracellular depletion of essential substrates and/or ions and to interfere with ribonucleic acid (RNA) and deoxyribonucleic acid (DNA).1 The azole antifungals, efinaconazole (Jublia®) and itraconazole tablets (Onmel®) and capsules (Sporanox®) works via inhibition of fungal lanosterol 14-alpha-demethylase, an enzyme necessary for the biosynthesis of ergosterol. By decreasing ergosterol concentrations, the fungal cell membrane permeability is increased, which results in leakage of cellular contents.2,5,6 Griseofulvin microsize (Grifulvin V®) and ultramicrosize (GRIS-PEG®) disrupts the mitotic spindle, arresting metaphase of cell division. Griseofulvin may also produce defective DNA that is unable to replicate. The ultramicrosize tablets are absorbed from the gastrointestinal tract at approximately one and one-half times that of microsize griseofulvin, which allows for a lower dose of griseofulvin to be administered.3,4 Tavaborole (Kerydin®), is an oxaborole antifungal that interferes with protein biosynthesis by inhibiting leucyl-transfer ribonucleic acid (tRNA) synthase (LeuRS), which prevents translation of tRNA by LeuRS.7 The final agent used for the treatment of onychomycosis, terbinafine hydrochloride (Lamisil®), is an allylamine antifungal.
    [Show full text]
  • Pulmonary Aspergillosis: What CT Can Offer Before Radiology Section It Is Too Late!
    DOI: 10.7860/JCDR/2016/17141.7684 Review Article Pulmonary Aspergillosis: What CT can Offer Before Radiology Section it is too Late! AKHILA PRASAD1, KSHITIJ AGARWAL2, DESH DEEPAK3, SWAPNDEEP SINGH ATWAL4 ABSTRACT Aspergillus is a large genus of saprophytic fungi which are present everywhere in the environment. However, in persons with underlying weakened immune response this innocent bystander can cause fatal illness if timely diagnosis and management is not done. Chest infection is the most common infection caused by Aspergillus in human beings. Radiological investigations particularly Computed Tomography (CT) provides the easiest, rapid and decision making information where tissue diagnosis and culture may be difficult and time-consuming. This article explores the crucial role of CT and offers a bird’s eye view of all the radiological patterns encountered in pulmonary aspergillosis viewed in the context of the immune derangement associated with it. Keywords: Air-crescent, Fungal ball, Halo sign, Invasive aspergillosis INTRODUCTION diagnostic pitfalls one encounters and also addresses the crucial The genus Aspergillus comprises of hundreds of fungal species issue as to when to order for the CT. ubiquitously present in nature; predominantly in the soil and The spectrum of disease that results from the Aspergilla becoming decaying vegetation. Nearly, 60 species of Aspergillus are a resident in the lung is known as ‘Pulmonary Aspergillosis’. An medically significant, owing to their ability to cause infections inert colonization of pulmonary cavities like in cases of tuberculosis in human beings affecting multiple organ systems, chiefly the and Sarcoidosis, where cavity formation is quite common, makes lungs, paranasal sinuses, central nervous system, ears and skin.
    [Show full text]
  • PRIOR AUTHORIZATION CRITERIA BRAND NAME (Generic) SPORANOX ORAL CAPSULES (Itraconazole)
    PRIOR AUTHORIZATION CRITERIA BRAND NAME (generic) SPORANOX ORAL CAPSULES (itraconazole) Status: CVS Caremark Criteria Type: Initial Prior Authorization Policy FDA-APPROVED INDICATIONS Sporanox (itraconazole) Capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: 1. Blastomycosis, pulmonary and extrapulmonary 2. Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and 3. Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy. Specimens for fungal cultures and other relevant laboratory studies (wet mount, histopathology, serology) should be obtained before therapy to isolate and identify causative organisms. Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, antiinfective therapy should be adjusted accordingly. Sporanox Capsules are also indicated for the treatment of the following fungal infections in non-immunocompromised patients: 1. Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium), and 2. Onychomycosis of the fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment, appropriate nail specimens for laboratory testing (KOH preparation, fungal culture, or nail biopsy) should be obtained to confirm the diagnosis of onychomycosis. Compendial Uses Coccidioidomycosis2,3
    [Show full text]
  • Detection of Histoplasma DNA from Tissue Blocks by a Specific
    Journal of Fungi Article Detection of Histoplasma DNA from Tissue Blocks by a Specific and a Broad-Range Real-Time PCR: Tools to Elucidate the Epidemiology of Histoplasmosis Dunja Wilmes 1,*, Ilka McCormick-Smith 1, Charlotte Lempp 2 , Ursula Mayer 2 , Arik Bernard Schulze 3 , Dirk Theegarten 4, Sylvia Hartmann 5 and Volker Rickerts 1 1 Reference Laboratory for Cryptococcosis and Uncommon Invasive Fungal Infections, Division for Mycotic and Parasitic Agents and Mycobacteria, Robert Koch Institute, 13353 Berlin, Germany; [email protected] (I.M.-S.); [email protected] (V.R.) 2 Vet Med Labor GmbH, Division of IDEXX Laboratories, 71636 Ludwigsburg, Germany; [email protected] (C.L.); [email protected] (U.M.) 3 Department of Medicine A, Hematology, Oncology and Pulmonary Medicine, University Hospital Muenster, 48149 Muenster, Germany; [email protected] 4 Institute of Pathology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany; [email protected] 5 Senckenberg Institute for Pathology, Johann Wolfgang Goethe University Frankfurt, 60323 Frankfurt am Main, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-30-187-542-862 Received: 10 November 2020; Accepted: 25 November 2020; Published: 27 November 2020 Abstract: Lack of sensitive diagnostic tests impairs the understanding of the epidemiology of histoplasmosis, a disease whose burden is estimated to be largely underrated. Broad-range PCRs have been applied to identify fungal agents from pathology blocks, but sensitivity is variable. In this study, we compared the results of a specific Histoplasma qPCR (H. qPCR) with the results of a broad-range qPCR (28S qPCR) on formalin-fixed, paraffin-embedded (FFPE) tissue specimens from patients with proven fungal infections (n = 67), histologically suggestive of histoplasmosis (n = 36) and other mycoses (n = 31).
    [Show full text]
  • Application to Add Itraconazole and Voriconazole to the Essential List of Medicines for Treatment of Fungal Diseases – Support Document
    Application to add itraconazole and voriconazole to the essential list of medicines for treatment of fungal diseases – Support document 1 | Page Contents Page number Summary 3 Centre details supporting the application 3 Information supporting the public health relevance and review of 4 benefits References 7 2 | Page 1. Summary statement of the proposal for inclusion, change or deletion As a growing trend of invasive fungal infections has been noticed worldwide, available few antifungal drugs requires to be used optimally. Invasive aspergillosis, systemic candidiasis, chronic pulmonary aspergillosis, fungal rhinosinusitis, allergic bronchopulmonary aspergillosis, phaeohyphomycosis, histoplasmosis, sporotrichosis, chromoblastomycosis, and relapsed cases of dermatophytosis are few important concern of southeast Asian regional area. Considering the high burden of fungal diseases in Asian countries and its associated high morbidity and mortality (often exceeding 50%), we support the application of including major antifungal drugs against filamentous fungi, itraconazole and voriconazole in the list of WHO Essential Medicines (both available in oral formulation). The inclusion of these oral effective antifungal drugs in the essential list of medicines (EML) would help in increased availability of these agents in this part of the world and better prompt management of patients thereby reducing mortality. The widespread availability of these drugs would also stimulate more research to facilitate the development of better combination therapies.
    [Show full text]
  • Estimation of the Burden of Serious Human Fungal Infections in Malaysia
    Journal of Fungi Article Estimation of the Burden of Serious Human Fungal Infections in Malaysia Rukumani Devi Velayuthan 1,*, Chandramathi Samudi 1, Harvinder Kaur Lakhbeer Singh 1, Kee Peng Ng 1, Esaki M. Shankar 2,3 ID and David W. Denning 4,5 ID 1 Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia; [email protected] (C.S.); [email protected] (H.K.L.S.); [email protected] (K.P.N.) 2 Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia; [email protected] 3 Department of Microbiology, School of Basic & Applied Sciences, Central University of Tamil Nadu (CUTN), Thiruvarur 610 101, Tamil Nadu, India 4 Faculty of Biology, Medicine and Health, The University of Manchester and Manchester Academic Health Science Centre, Oxford Road, Manchester M13 9PL, UK; [email protected] 5 The National Aspergillosis Centre, Education and Research Centre, Wythenshawe Hospital, Manchester M23 9LT, UK * Correspondence: [email protected]; Tel.: +60-379-492-755 Received: 11 December 2017; Accepted: 14 February 2018; Published: 19 March 2018 Abstract: Fungal infections (mycoses) are likely to occur more frequently as ever-increasingly sophisticated healthcare systems create greater risk factors. There is a paucity of systematic data on the incidence and prevalence of human fungal infections in Malaysia. We conducted a comprehensive study to estimate the burden of serious fungal infections in Malaysia. Our study showed that recurrent vaginal candidiasis (>4 episodes/year) was the most common of all cases with a diagnosis of candidiasis (n = 501,138).
    [Show full text]
  • Histoplasmosis in an Immunocompetent Host: a Rare Case Report
    International Journal of Research in Medical Sciences Kriplani DM et al. Int J Res Med Sci. 2017 Mar;5(3):1148-1150 www.msjonline.org pISSN 2320-6071 | eISSN 2320-6012 DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20170681 Case Report Histoplasmosis in an immunocompetent host: a rare case report Dipsha M. Kriplani1*, Katha A. Kante1, Janak K. Maniar2, Shaila R. Khubchandani1 1Department of Pathology, Jaslok Hospital and Research Centre, Mumbai, India 2Department of Infectious diseases, Jaslok Hospital and Research Centre, Mumbai, India Received: 04 January 2017 Revised: 06 January 2017 Accepted: 04 February 2017 *Correspondence: Dr. Dipsha M. Kriplani, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Histoplasmosis, a systemic mycosis caused by Histoplasma capsulatum manifests clinically in immunocompromised patients as acute or chronic pulmonary infection or as a progressive disseminated disease. In immunocompetent hosts, the disease is usually self-limited or presents as flu-like symptoms. It is endemic in North, Central and South America as well as parts of Europe and Africa. We report a case of a 76-year-old diabetic, HIV negative patient who presented with white nodular patches on the tongue and gingiva which were reported as histoplasmosis on histopathology. He also had idiopathic CD4 lymphocytopenia and thrombocytopenia. Keywords: Histoplasmosis, Histoplasma capsulatum, Immunocompetent, Idiopathic CD4 lymphocytopenia INTRODUCTION dry cough, loss of appetite and weakness for one month.
    [Show full text]
  • Diagnosis of Histoplasmosis
    Brazilian Journal of Microbiology (2006) 37:1-13 ISSN 1517-8382 DIAGNOSIS OF HISTOPLASMOSIS Allan Jefferson Guimarães1,2; Joshua D. Nosanchuk2; Rosely Maria Zancopé-Oliveira1* 1Serviço de Micologia, Departamento de Micro-Imuno-Parasitologia, Instituto de Pesquisa Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil; 2Department of Medicine (Division of Infectious Diseases) & Microbiology and Imunology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York Submitted: January 31, 2006; Approved: February 13, 2006 ABSTRACT Endemic mycoses can be challenging to diagnose and accurate interpretation of laboratory data is important to ensure the most appropriate treatment for the patients. Although the definitive diagnosis of histoplasmosis (HP), one of the most frequent endemic mycoses in the world, is achieved by direct diagnosis performed by micro and/or macroscopic observation of Histoplasma capsulatum (H. capsulatum), serologic evidence of this fungal infection is important since the isolation of the etiologic agents is time-consuming and insensitive. A variety of immunoassays have been used to detect specific antibodies to H. capsulatum. The most applied technique for antibody detection is immunodiffusion with sensitivity between 70 to 100 % and specificity of 100%, depending on the clinical form. The complement fixation (CF) test, a methodology extensively used on the past, is less specific (60 to 90%). Detecting fungal antigens by immunoassays is valuable in immunocompromised individuals where such assays achieve positive predictive values of 96-98%. Most current tests in diagnostic laboratories still utilize unpurified antigenic complexes from either whole fungal cells or their culture filtrates. Emphasis has shifted, however, to clinical immunoassays using highly purified and well-characterized antigens including recombinant antigens.
    [Show full text]
  • Histoplasmosis
    HISTOPLASMOSIS What is histoplasmosis? older persons, in particular those with underlying illnesses such as diabetes and chronic lung disease, Histoplasmosis is an infectious disease caused by are at increased risk for developing symptomatic inhaling spores of a fungus called Histoplasma histoplasmosis. capsulatum. Histoplasmosis is not contagious; it cannot be transmitted from an infected person or People with weakened immune systems are at great- animal to someone else. est risk for developing severe and disseminated histoplasmosis. Included in this high-risk group are What are the symptoms of histoplasmosis? persons with AIDS or cancer and persons receiving cancer chemotherapy; high-dose, long-term steroid Histoplasmosis primarily affects a person’s lungs, therapy; or other immuno-suppressive drugs. and its symptoms vary greatly. The vast majority of infected people are asymptomatic (have no appar- Before 2000, a person could learn from a histo- ent ill effects) or they experience symptoms so plasmin skin test whether he or she had been pre- mild they do not seek medical attention. If symp- viously infected by H. capsulatum. However, the toms do occur, they will usually start within 3 to 17 manufacturing of histoplasmin was discontinued in days after exposure, with an average of 10 days. 2000, and the skin testing reagents were still Histoplasmosis can appear as a mild, flu-like respi- unavailable in 2004. A previous infection can pro- ratory illness and has a combination of symptoms, vide partial immunity to reinfection. Since a posi- including malaise (a general ill feeling), fever, tive skin test does not mean that a person is com- chest pain, dry or nonproductive cough, headache, pletely immune to reinfection, appropriate expo- loss of appetite, shortness of breath, joint and mus- sure precautions should be taken regardless of a cle pains, chills, and hoarseness.
    [Show full text]
  • Fungal Infections in PIDD Patients
    Funga l Infections in PIDD Patients PIDD patients are more prone to certain types of infections. Knowing which ones they are most susceptible to and how they are most commonly treated can help to minimize the risk. By Alexandra F. Freeman, MD, and Anahita Agharahimi, MSN, CRNP 16 December-January 2014 www.IGLiving.com IG Living! ndividuals with primary immune deficiencies (PID Ds) are (paronychia) or the finger nails and toenails themselves at greater risk for recurrent infections compared with (onychomycosis). Candida can enter the bloodstream and Ithose with normal immune systems. PIDD patients cause more severe infections when the normal skin barriers fre quently have a genetic defect that causes an abnormality are compromised such as with central venous access lines in the number and/or function of one or more compo - (long-term IV access) that are sometimes needed for various nents of the immune system that fights infections. These treatments. These invasive infections usually cause infections can be predominantly viral, bacterial or fungal, fever and more acute illness compared with the more depending on the type of white blood cells affected by the mild infections such as thrush and vaginal yeast infections. specific immune deficiency . For instance, neutrophil Ringworm is also caused by yeasts, including Trichophyton abnormalities lead to recurrent bacterial and mold infections ; and Microsporum species, that cause rashes on the skin or B lymphocytes typically lead to bacterial infections, more scalp. Tinea versicolor is caused by the yeast Malassezia specifically those that antibodies prevent such as furfur and causes a rash usually on the trunk.
    [Show full text]
  • Immune Thrombocytopenic Purpura Secondary to Histoplasmosis
    Elmer ress Case Report J Med Cases. 2015;6(11):483-484 Immune Thrombocytopenic Purpura Secondary to Histoplasmosis Anupam Guptaa, Ivan Kamikovskia, Armin Kamyaba, Michael Jacobsa, b Abstract Introduction Immune thrombocytopenic purpura (ITP) is a relatively common ac- Idiopathic thrombocytopenic purpura (ITP) is an antibody- quired bleeding disorder characterized by autoimmune destruction of mediated destruction of platelets by the reticuloendothelial platelets. In adults, the annual incidence is around 1.6/100,000, com- system. The triggering etiology in most cases is unknown, but mon in middle aged females. In patients with ITP, physical examina- it has been reported to be associated with certain infections tion is usually normal aside from bleeding manifestations, such as such as hepatitis C virus (HCV), human immunodeficiency vi- petechiae, ecchymoses, and purpura. The three key diagnostic criteria rus (HIV), Ebstein-Barr virus (EBV) and Helicobacter pylori. for ITP are isolated thrombocytopenia with otherwise normal periph- Histoplasmosis is the most common of all North American eral complete blood count and smear, an absence of hepatospleno- fungal infections. The lymphogenous reaction to Histoplasma megaly and lymphadenopathy on physical examination, and platelet can cause mediastinal lymph node enlargement, bronchiecta- response to classic ITP therapy. Review of the literature has shown sis, constrictive pericarditis, and rarely, idiopathic thrombocy- case reports of disseminated histoplasmosis presenting with throm- topenia. We report a case of ITP secondary to histoplasmosis bocytopenia. Our patient comes from a geographic location where in an immunocompetent patient. histoplasmosis is endemic. Most cases of histoplasmosis have mild symptoms and usually escape diagnosis. The microconidia formed in the mold phase of Histoplasma capsulatum are easily aerosolized, Case Report inhaled into the lungs, and then phagocytized by alveolar macrophag- es.
    [Show full text]